Spruce Biosciences (SPRB) Revenue & Revenue Breakdown
Spruce Biosciences Revenue Highlights
Latest Revenue (Y)
$4.91M
Spruce Biosciences Revenue by Period
Spruce Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $4.91M | -51.32% |
| 2023-12-31 | $10.09M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Spruce Biosciences generated $4.91M in revenue during NA 2024, up -51.32% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Spruce Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $697.00K | 15.78% |
| 2024-09-30 | $602.00K | -62.61% |
| 2024-06-30 | $1.61M | -19.58% |
| 2024-03-31 | $2.00M | -30.65% |
| 2023-12-31 | $2.89M | -6.05% |
| 2023-09-30 | $3.07M | 41.94% |
| 2023-06-30 | $2.17M | 10.23% |
| 2023-03-31 | $1.96M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | - |
Spruce Biosciences generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Spruce Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| EQ | Equillium | $41.09M | - |
| CUE | Cue Biopharma | $5.49M | $2.95M |
| SPRB | Spruce Biosciences | $4.91M | - |
| HOWL | Werewolf Therapeutics | $1.89M | - |
| VTVT | vTv Therapeutics | $1.02M | - |
| COEP | Coeptis Therapeutics | - | $62.87K |
| OSTX | OS Therapies | - | - |
| OTLK | Outlook Therapeutics | - | - |
| IOBT | IO Biotech | - | - |
| NRXP | NRx Pharmaceuticals | - | $242.00K |